Ibex Investors’s Omnicell OMCL Stock Holding History

Ibex Investors’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,912	Closed	-$209K	–	224
2018 Q3	$209K	Buy	+2,912	New	+$183K	0.12%	115

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ibex Investors's OMCL Position: Q4 2018 in Review

Ibex Investors sold out of Omnicell (OMCL) in Q4 2018, closing a stake of 2,912 shares — an estimated $209K sold.

Ibex Investors first reported a position in OMCL in Q3 2018 and held it in 1 quarter. The position peaked at $209K in Q3 2018. 290 funds tracked by Wall St. Rank hold OMCL as of Q4 2018.

Ibex Investors reported no remaining Omnicell position as of Q4 2018 after selling out during the quarter.
Ibex Investors sold 2,912 Omnicell shares in Q4 2018, an estimated $209K.
Ibex Investors first reported a position in Omnicell in Q3 2018 and held it in 1 quarter.
Ibex Investors's Omnicell position peaked at $209K in Q3 2018.
290 funds tracked by Wall St. Rank held Omnicell as of Q4 2018.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.